Intermagnetics income leaps

Article

Increased sales of high-field MR magnets contributed to income growth at Intermagnetics General during the fourth quarter of fiscal 2003. Income rose 27% to $4.4 million from $3.4 million in the previous-year period. Excluding one-time items that

Increased sales of high-field MR magnets contributed to income growth at Intermagnetics General during the fourth quarter of fiscal 2003. Income rose 27% to $4.4 million from $3.4 million in the previous-year period. Excluding one-time items that resulted in a net charge of about $1 million, net income for the fiscal year ended May 25 was $15.9 million. Reported net income was $14.9 million, including one-time charges associated with the sale of securities, which was partially offset by a favorable settlement of long-standing trade litigation. These compare with income of $14.6 million in the previous fiscal year, excluding nonrecurring items that resulted in a net gain of about $6 million. Reported net income for the year ended May 26, 2002, was $20.6 million, including gains from the divestiture of the company's LTS wire and helium gas businesses, which was partially offset by charges related to restructuring of the Instrumentation segment and the write-down of investments. Net sales for the recently completed fiscal year were $147.4 million compared with $144.3 million from ongoing operations the prior year.

MR sales increased revenue to $125.1 million from $120.7 million. Operating profit increased at a higher rate than revenue because of improved product mix, notably among higher field strength 3T and 1.5T magnets. The company predicted continued increases in sales of its recently introduced 3T superconducting MRI magnet. Added revenues could accrue around fiscal 2005 with the commercial delivery of 1T open magnets.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.